Categories Earnings, Health Care

Earnings Summary: Thermo Fisher Scientific (TMO) reports Q3 2024 results

Thermo Fisher Scientific Inc. (NYSE: TMO) on Wednesday reported financial results for the third quarter of 2024. The company also issued full-year guidance.

  • Third-quarter revenue increased modestly to $10.60 billion from $10.57 billion in the comparable period last year
  • Earnings, on a reported basis, declined to $4.25 in the September quarter from $4.42 in the year-ago quarter
  • On an adjusted basis, Q3 earnings dropped to $5.28 per share from $5.69 per share in the third quarter of 2023
  • Operating income for the third quarter was $1.84 billion, compared to $1.86 billion in the year-ago quarter
  • The company raised its full-year EPS guidance to the range of $21.35 to $22.07 from the previous guidance of $21.29 to $22.07
  • It continues to expect fiscal 2024 revenue to be between $42.4 billion and $43.3 billion

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

INTU Earnings: Intuit reports higher Q3 revenue and profit; results beat

Financial technology company Intuit Inc. (NASDAQ: INTU) on Thursday reported stronger-than-expected revenue and adjusted earnings for the third quarter of 2025. The Mountain View-headquartered company’s third-quarter revenue was $7.75 billion,

Against a challenging backdrop, Lowe’s (LOW) is focusing on these two pillars of its strategy

Shares of Lowe’s Companies, Inc. (NYSE: LOW) were down over 1% on Thursday. The stock has dropped 8% over the past three months. The company saw sales and earnings decline

Earnings Preview: Can Salesforce regain its growth momentum this year?

Salesforce, Inc. (NYSE: CRM) has constantly innovated its products and services after successfully adopting the SaaS business model years ago. The company's growth has slowed in recent quarters, and its

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top